Home
Categories
EXPLORE
True Crime
Comedy
Society & Culture
Business
Sports
TV & Film
Technology
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts112/v4/8e/c5/a1/8ec5a12c-b5ea-0917-968d-114148ca47f8/mza_11631062009583709663.jpeg/600x600bb.jpg
DermConsult
ReachMD
45 episodes
1 week ago
There’s a lot dermatology specialists need to consider when ensuring patients have healthy skin. And at a time when clinical research is increasingly defining skin conditions—and the practice of dermatology itself—as “more than skin deep,” turn to DermConsult. In this special series, dermatology specialists share their expert advice on the diagnosis and treatment of a variety of skin conditions. They also explore the latest clinical research and their very own case studies, so you can rest assured you’ll have access to everything you need to know about the body’s largest organ.
Show more...
Science
Medicine
RSS
All content for DermConsult is the property of ReachMD and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
There’s a lot dermatology specialists need to consider when ensuring patients have healthy skin. And at a time when clinical research is increasingly defining skin conditions—and the practice of dermatology itself—as “more than skin deep,” turn to DermConsult. In this special series, dermatology specialists share their expert advice on the diagnosis and treatment of a variety of skin conditions. They also explore the latest clinical research and their very own case studies, so you can rest assured you’ll have access to everything you need to know about the body’s largest organ.
Show more...
Science
Medicine
https://is1-ssl.mzstatic.com/image/thumb/Podcasts112/v4/8e/c5/a1/8ec5a12c-b5ea-0917-968d-114148ca47f8/mza_11631062009583709663.jpeg/600x600bb.jpg
Examining Delgocitinib for Chronic Hand Eczema: Results from the DELTA Trials
DermConsult
1 month ago
Examining Delgocitinib for Chronic Hand Eczema: Results from the DELTA Trials
Guest: Robert Bissonnette, MD, FRCPC

The DELTA 1 and DELTA 2 trials examined the efficacy and safety of the topical pan-JAK inhibitor delgocitinib in patients with moderate to severe chronic hand eczema. Based on the findings, no new safety signals were observed, and nearly half of patients achieved a 75 percent improvement in HECSI scores as well as meaningful relief in itch, pain, and quality of life. Here to talk about the trials’ design and findings—as well as his own firsthand experience treating patients who were enrolled in the trials—is board-certified dermatologist Dr. Robert Bissonnette.

DermConsult
There’s a lot dermatology specialists need to consider when ensuring patients have healthy skin. And at a time when clinical research is increasingly defining skin conditions—and the practice of dermatology itself—as “more than skin deep,” turn to DermConsult. In this special series, dermatology specialists share their expert advice on the diagnosis and treatment of a variety of skin conditions. They also explore the latest clinical research and their very own case studies, so you can rest assured you’ll have access to everything you need to know about the body’s largest organ.